The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
Introduction: Patients with hypertrophic cardiomyopathy (HCM) are at risk for lethal ventricular arrhythmia, but the electrophysiological substrate behind this is not well-understood. We used non-invasive electrocardiographic imaging to characterize patients with HCM, including cardiac arrest surviv...
Autori principali: | Chow, J, Leong, KMW, Shun-Shin, M, Jones, S, Guttmann, OP, Mohiddin, SA, Lambiase, P, Elliott, PM, Ormerod, JOM, Koa-Wing, M, Lefroy, D, Lim, PB, Linton, NWF, Ng, FS, Qureshi, NA, Whinnett, ZI, Peters, NS, Francis, DP, Varnava, AM, Kanagaratnam, P |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
Frontiers Media
2024
|
Documenti analoghi
Documenti analoghi
-
The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
di: Ji-Jian Chow, et al.
Pubblicazione: (2024-08-01) -
Ventricular Conduction Stability Noninvasively Identifies an Arrhythmic Substrate in Survivors of Idiopathic Ventricular Fibrillation
di: Ji‐Jian Chow, et al.
Pubblicazione: (2023-04-01) -
Pseudo-arrhythmic ECG artifact
di: Satyajeet Singh, et al.
Pubblicazione: (2012-01-01) -
Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers
di: Lyon, A, et al.
Pubblicazione: (2018) -
Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
di: Coleman, JA, et al.
Pubblicazione: (2024)